Please login to the form below

Not currently logged in
Email:
Password:

Ferring collaborates on novel IBD drug development

Project in partnership with Paris-based Institut Pasteur

Ferring HQ 

Ferring Pharmaceuticals and non-profit biomedical research centre the Institut Pasteur are to collaborate on drug development for patients with inflammatory bowel disease (IBD).

The collaboration will aim to identify and develop bacteriophages, viruses that infect bacteria, which were commonly used prior to the development of antibiotics. The use of bacteriophages has again come to the forefront of the field due to concerns of increased bacterial resistance due to overuse of antibiotics.

Per Falk, executive VP and chief scientific officer at Ferring Pharmaceuticals, commented: “Data generated in our collaboration with the Institut Pasteur and the fact that many patients with IBD are colonised by bacteria known to cause aggressive infections, show us that bacteriophages have an important role to play in the treatment of IBD.

“A dedicated programme will now start to develop a Ferring medicine from these research findings.”

Following a recent finding linking infection to the onset of Crohn's Disease, a chronic IBD condition, Ferring and the Paris-based Institut Pasteur's new programme will aim to test the feasibility and efficacy of these bacteriophages in controlled clinical trials.

Isabelle Buckle, executive VP, technology transfer and industrial partnership at the Insistut Pasteur, added: “It is very exciting to see bacteriophages, discovered many years ago, return to bring a real advantage to patients today.

“The collaboration with Ferring is a very good example of a successful academic and industry partnership. We believe that IBD patients will benefit from it.”

Article by
Kirstie Pickering

20th April 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics